Home > Openweb : Practical Cancer Pharmacy Workbook
OPEN Education Programs
The Practical Cancer Pharmacy: Workbook
"The Practical Cancer Pharmacy Workbook"
Making Informed Purchasing Decisions and Explaining Their Value
An easy-to-read tool for use in making choices among competing anti-cancer drugs
This publication is available in print and PDF format at no cost to ACCC members. Members, click here to order and download the workbook. You will need to log in to the members' ONLINE STORE. After you order, click on MY TRANSACTIONS/DOCUMENTS to download.
Non–members will be charged a fee (via ACCC's online store) for the workbook. The cost of the print copy is just $20. The PDF download is $16. Non-members, please click here to order. Follow the directions to log in to ACCC's ONLINE STORE. After you order, click on MY TRANSACTIONS/DOCUMENTS to download.
"The Practical Cancer Pharmacy Workbook" begins with an overview of PE. Working under the principle that the best way to learn is to do, the workbook includes an exercise in which participants will conduct their own PE analysis, and provides information to help guide participants through this exercise.
The text is presented in non-technical terms in order to make the subject matter more accessible to those with little familiarity with formal methods for health technology assessment. The easy-to-read style is also used because it is our conviction that the results of any PE analysis will be more compelling if communicated simply.
That said, PE is a large and complex field. Covering all of the discipline is beyond the capabilities of one publication. Our goal, therefore, is to give readers sufficient grounding in the discipline that they can both understand PE studies done by others and contribute to PE analyses undertaken at their own institutions.
Why PE?
Pharmacoeconomics (PE) offers the opportunity for the pharmacy and financial teams to move past the short-term orientation of considering only cost in deciding which drugs to purchase. PE was developed to establish the optimal basis for clinical decision-making: take data for both costs and clinical consequences and combine them into a single measure.
An emphasis solely on purchase price ignores the reality that there are numerous other “costs” associated with drug use, including dosing, treatment side effects, and costs needed to support the use of a drug. Consequently, providers who rely entirely on drugs that initially cost less often spend considerably more because of the additional staff, space, and supportive resources that these drugs can require.
Our Supporters
This educational program was made possible through an educational grant from Millennium: The Takeda Oncology Company.